Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
42
INFY Quote, Financials, Valuation and Earnings
Last price:
$18.67
Seasonality move
:
0.22%
Day range:
$18.07 - $19.45
52-week range:
$15.82 - $30.00
Dividend yield:
2.69%
P/E ratio:
24.98x
P/S ratio:
4.04x
P/B ratio:
8.47x
Volume:
37.6M
Avg. volume:
16.2M
1-year change:
-14.04%
Market cap:
$78.3B
Revenue:
$19.3B
EPS (TTM):
$0.77
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $13.5B | $16.3B | $18.3B | $18.6B | $19.3B | |
| Revenue Growth (YoY) | 5.7% | 20.62% | 11.86% | 1.64% | 3.86% | |
| Cost of Revenues | $9.5B | $11.7B | $13.4B | $13.7B | $14.2B | |
| Gross Profit | $4.1B | $4.6B | $4.8B | $4.9B | $5.1B | |
| Gross Profit Margin | 29.96% | 28.35% | 26.49% | 26.2% | 26.34% | |
| R&D Expenses | $127.3M | $71M | $129.7M | $135M | $153.3M | |
| Selling, General & Admin | $432.9M | $481M | $626M | $691.9M | $707.7M | |
| Other Inc / (Exp) | $81M | $87M | $109M | $66M | $74M | |
| Operating Expenses | $679.2M | $811M | $934.3M | $963.4M | $937M | |
| Operating Income | $3.4B | $3.8B | $3.9B | $3.9B | $4.1B | |
| Net Interest Expenses | $26.3M | $26.8M | $35.3M | $56.8M | $49.2M | |
| EBT. Incl. Unusual Items | $3.6B | $4B | $4.1B | $4.3B | $4.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $970.6M | $1.1B | $1.1B | $1.2B | $1.3B | |
| Net Income to Company | $2.6B | $3B | $3B | $3.2B | $3.2B | |
| Minority Interest in Earnings | $9.7M | $4.8M | $1.6M | $1.8M | $4.4M | |
| Net Income to Common Excl Extra Items | $2.6B | $3B | $3B | $3.2B | $3.2B | |
| Basic EPS (Cont. Ops) | $0.61 | $0.70 | $0.72 | $0.77 | $0.76 | |
| Diluted EPS (Cont. Ops) | $0.61 | $0.70 | $0.72 | $0.76 | $0.76 | |
| Weighted Average Basic Share | $4.2B | $4.2B | $4.2B | $4.1B | $4.1B | |
| Weighted Average Diluted Share | $4.3B | $4.2B | $4.2B | $4.1B | $4.2B | |
| EBITDA | $3.8B | $4.3B | $4.4B | $4.5B | $4.7B | |
| EBIT | $3.4B | $3.8B | $3.9B | $3.9B | $4.1B | |
| Revenue (Reported) | $13.5B | $16.3B | $18.3B | $18.6B | $19.3B | |
| Operating Income (Reported) | $3.4B | $3.8B | $3.9B | $3.9B | $4.1B | |
| Operating Income (Adjusted) | $3.4B | $3.8B | $3.9B | $3.9B | $4.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.3B | $4.7B | $4.7B | $4.9B | $5.1B | |
| Revenue Growth (YoY) | 21.01% | 9.62% | 0.04% | 6.08% | 3.21% | |
| Cost of Revenues | $2.9B | $3.2B | $3.3B | $3.4B | $3.7B | |
| Gross Profit | $1.4B | $1.4B | $1.4B | $1.5B | $1.4B | |
| Gross Profit Margin | 32.8% | 30.68% | 29.8% | 30.28% | 28.2% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $396M | $427.5M | $433.2M | $442M | -- | |
| Other Inc / (Exp) | $15M | $84M | $35M | $31M | -- | |
| Operating Expenses | $384.3M | $409.8M | $416.7M | $422.5M | $481.6M | |
| Operating Income | $1B | $1B | $972.5M | $1.1B | $958.1M | |
| Net Interest Expenses | $7.1M | $9.7M | $15.7M | $12M | $11.2M | |
| EBT. Incl. Unusual Items | $1.1B | $1.1B | $1B | $1.1B | $1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $283M | $285.2M | $301M | $337.3M | $287.7M | |
| Net Income to Company | $777.9M | $802.3M | $733.5M | $813.6M | $736.5M | |
| Minority Interest in Earnings | $1.7M | -- | $840.7K | $1.9M | $1.3M | |
| Net Income to Common Excl Extra Items | $776.8M | $801M | $734.1M | $807.9M | $748.2M | |
| Basic EPS (Cont. Ops) | $0.18 | $0.19 | $0.18 | $0.19 | $0.18 | |
| Diluted EPS (Cont. Ops) | $0.18 | $0.19 | $0.18 | $0.19 | $0.18 | |
| Weighted Average Basic Share | $4.2B | $4.2B | $4.1B | $4.1B | $4.1B | |
| Weighted Average Diluted Share | $4.2B | $4.2B | $4.1B | $4.2B | $4.1B | |
| EBITDA | $1.1B | $1.2B | $1.1B | $1.2B | $1.1B | |
| EBIT | $1B | $1B | $972.5M | $1.1B | $958.1M | |
| Revenue (Reported) | $4.3B | $4.7B | $4.7B | $4.9B | $5.1B | |
| Operating Income (Reported) | $1B | $1B | $972.5M | $1.1B | $958.1M | |
| Operating Income (Adjusted) | $1B | $1B | $972.5M | $1.1B | $958.1M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $15.6B | $18B | $18.5B | $19.1B | $19.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $10.4B | $12.5B | $12.9B | $13.3B | $13.9B | |
| Gross Profit | $5.2B | $5.5B | $5.6B | $5.8B | $6B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.5B | $1.7B | $1.8B | $1.8B | $1.4B | |
| Other Inc / (Exp) | $136M | $217M | -$28M | $154M | -- | |
| Operating Expenses | $1.5B | $1.6B | $1.7B | $1.7B | $1.9B | |
| Operating Income | $3.8B | $3.9B | $3.9B | $4.1B | $4.1B | |
| Net Interest Expenses | $27.1M | $31.9M | $53.3M | $50.7M | $47.4M | |
| EBT. Incl. Unusual Items | $4B | $4.1B | $4.1B | $4.6B | $4.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1B | $1.1B | $1.2B | $1.3B | $1.2B | |
| Net Income to Company | $2.9B | $3B | $3B | $3.3B | $3.2B | |
| Minority Interest in Earnings | $3.8M | $2.1M | $1.9M | $4.5M | $3.5M | |
| Net Income to Common Excl Extra Items | $2.9B | $3B | $3B | $3.3B | $3.2B | |
| Basic EPS (Cont. Ops) | $0.69 | $0.72 | $0.71 | $0.80 | $0.78 | |
| Diluted EPS (Cont. Ops) | $0.69 | $0.72 | $0.71 | $0.80 | $0.77 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $4.2B | $4.4B | $4.5B | $4.6B | $4.6B | |
| EBIT | $3.8B | $3.9B | $3.9B | $4.1B | $4.1B | |
| Revenue (Reported) | $15.6B | $18B | $18.5B | $19.1B | $19.9B | |
| Operating Income (Reported) | $3.8B | $3.9B | $3.9B | $4.1B | $4.1B | |
| Operating Income (Adjusted) | $3.8B | $3.9B | $3.9B | $4.1B | $4.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $12B | $13.7B | $14B | $14.6B | $15.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $8B | $9.6B | $9.8B | $10.1B | $10.6B | |
| Gross Profit | $4B | $4.1B | $4.2B | $4.4B | $4.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.2B | $1.2B | $1.3B | $1.4B | $993.5M | |
| Other Inc / (Exp) | $92M | $168M | $92M | $119M | $110M | |
| Operating Expenses | $1.1B | $1.2B | $1.3B | $1.3B | $1.4B | |
| Operating Income | $2.9B | $2.9B | $3B | $3.1B | $3.1B | |
| Net Interest Expenses | $20.2M | $25.3M | $43.4M | $37.4M | $35.6M | |
| EBT. Incl. Unusual Items | $3B | $3.1B | $3.1B | $3.3B | $3.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $823.4M | $862.9M | $903.8M | $981.3M | $943.5M | |
| Net Income to Company | $2.2B | $2.3B | $2.2B | $2.4B | $2.4B | |
| Minority Interest in Earnings | $3.5M | $885.5K | $1.2M | $3.8M | $3M | |
| Net Income to Common Excl Extra Items | $2.2B | $2.3B | $2.2B | $2.3B | $2.4B | |
| Basic EPS (Cont. Ops) | $0.52 | $0.54 | $0.53 | $0.57 | $0.58 | |
| Diluted EPS (Cont. Ops) | $0.52 | $0.54 | $0.53 | $0.57 | $0.58 | |
| Weighted Average Basic Share | $12.6B | $12.6B | $12.4B | $12.4B | $12.4B | |
| Weighted Average Diluted Share | $12.7B | $12.6B | $12.4B | $12.5B | $12.4B | |
| EBITDA | $3.2B | $3.3B | $3.4B | $3.6B | $3.5B | |
| EBIT | $2.9B | $2.9B | $3B | $3.1B | $3.1B | |
| Revenue (Reported) | $12B | $13.7B | $14B | $14.6B | $15.1B | |
| Operating Income (Reported) | $2.9B | $2.9B | $3B | $3.1B | $3.1B | |
| Operating Income (Adjusted) | $2.9B | $2.9B | $3B | $3.1B | $3.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4B | $3.5B | $2.6B | $3.6B | $4.7B | |
| Short Term Investments | $371M | $924M | $878M | $1.7B | $1.6B | |
| Accounts Receivable, Net | $3.7B | $4.5B | $5B | $5.2B | $5.1B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $177.9M | $288.9M | $358.6M | $441.8M | $408.7M | |
| Other Current Assets | -- | $43M | $32M | $21M | $11M | |
| Total Current Assets | $8.3B | $8.7B | $8.5B | $10.7B | $11.3B | |
| Property Plant And Equipment | $2.5B | $2.4B | $2.5B | $2.3B | $2.2B | |
| Long-Term Investments | $1.8B | $2B | $1.9B | $1.6B | $1.7B | |
| Goodwill | $832M | $817M | $882M | $875M | $1.2B | |
| Other Intangibles | $283M | $225M | $213M | $167M | $323M | |
| Other Long-Term Assets | -- | -- | -- | -- | $765M | |
| Total Assets | $14.8B | $15.6B | $15.3B | $16.5B | $17.4B | |
| Accounts Payable | $361.8M | $545.6M | $470.3M | $474.3M | $487.2M | |
| Accrued Expenses | $612M | $986M | -- | $986M | $991M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $101M | $115M | $151M | $235M | $287M | |
| Other Current Liabilities | $118M | $278M | $2.4B | $200M | $215M | |
| Total Current Liabilities | $3.3B | $4.4B | $4.8B | $4.7B | $5B | |
| Long-Term Debt | $627.4M | $607.3M | $858.7M | $767.4M | $675.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.3B | $5.6B | $6.1B | $5.9B | $6.2B | |
| Common Stock | $290.5M | $276.9M | $251.8M | $248.3M | $242.5M | |
| Other Common Equity Adj | $910M | $1.2B | $1.4B | $1.6B | $1.2B | |
| Common Equity | $10.4B | $9.9B | $9.2B | $10.6B | $11.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $58.9M | $50.9M | $47.2M | $41.4M | $45M | |
| Total Equity | $10.5B | $10B | $9.2B | $10.6B | $11.3B | |
| Total Liabilities and Equity | $14.8B | $15.5B | $15.3B | $16.5B | $17.4B | |
| Cash and Short Terms | $4B | $3.5B | $2.6B | $3.6B | $4.7B | |
| Total Debt | $728.3M | $722.4M | $1B | $1B | $962.5M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.7B | $2.5B | $2.6B | $3.6B | $3B | |
| Short Term Investments | $629M | $1.1B | $958M | $1.1B | -- | |
| Accounts Receivable, Net | $4.4B | $4.9B | $5.3B | $5.2B | $5.5B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $238.5M | $347.4M | $445.6M | $323.1M | $465.2M | |
| Other Current Assets | $3M | $41M | $1.4B | $16M | -- | |
| Total Current Assets | $8.1B | $8.6B | $9.2B | $10.1B | $10B | |
| Property Plant And Equipment | $2.4B | $2.4B | $2.4B | $2.2B | $2.1B | |
| Long-Term Investments | $1.8B | $1.7B | $1.6B | $1.4B | $1.3B | |
| Goodwill | $823M | $876M | -- | $1.2B | -- | |
| Other Intangibles | $239M | $222M | -- | $348M | -- | |
| Other Long-Term Assets | -- | -- | $1.3B | -- | -- | |
| Total Assets | $14.7B | $15.2B | $15.6B | $16.3B | $16B | |
| Accounts Payable | $506.1M | $578.8M | $459.7M | $429.3M | $536.9M | |
| Accrued Expenses | $901M | $948M | -- | $1B | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $112M | $138M | -- | $293M | -- | |
| Other Current Liabilities | $207M | $692M | $3B | $177M | -- | |
| Total Current Liabilities | $4.2B | $5B | $4.7B | $4.8B | $5.6B | |
| Long-Term Debt | $602.8M | $795M | $801.6M | $667.5M | $646.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.3B | $6.2B | $5.9B | $5.9B | $6.7B | |
| Common Stock | $282.1M | $252.1M | $248.8M | $242M | $225.2M | |
| Other Common Equity Adj | $1.1B | $1.4B | -- | $1.2B | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $50.7M | $46.1M | $45.7M | $43.9M | $47.5M | |
| Total Equity | $9.4B | $9B | $9.7B | $10.4B | $9.3B | |
| Total Liabilities and Equity | $14.7B | $15.2B | $15.6B | $16.3B | $16B | |
| Cash and Short Terms | $2.7B | $2.5B | $2.6B | $3.6B | $3B | |
| Total Debt | $714.6M | $933.2M | $1.1B | $960.2M | $978.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.6B | $3B | $3B | $3.2B | $3.2B | |
| Depreciation & Amoritzation | $440.1M | $466.5M | $525.7M | $565M | $569.2M | |
| Stock-Based Compensation | $44.9M | $55.7M | $64.6M | $78.8M | $94.9M | |
| Change in Accounts Receivable | -$247.2M | -$1.1B | -$880.5M | -$322.1M | -$209.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.3B | $3.5B | $3B | $3.3B | $4.5B | |
| Capital Expenditures | $283.8M | $290M | $320.9M | $265.8M | $264.6M | |
| Cash Acquisitions | $192.4M | $7.4M | $120.7M | $14.4M | $373.2M | |
| Cash From Investing | -$1.2B | -$1.1B | -$340.2M | -$820.7M | -$471.5M | |
| Dividends Paid (Ex Special Dividend) | $1.2B | $1.7B | $1.7B | $1.8B | $2.4B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$94M | -$125M | -$151M | -$245M | -$396M | |
| Repurchase of Common Stock | -- | $1.5B | $1.4B | -- | -- | |
| Other Financing Activities | $1M | $4M | -$46M | -$95M | -$64M | |
| Cash From Financing | -$1.3B | -$3.3B | -$3.3B | -$2.1B | -$2.9B | |
| Beginning Cash (CF) | $3.7B | $2.6B | $1.8B | $2.1B | $3.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $817M | -$972M | -$659.4M | $315.6M | $1.1B | |
| Ending Cash (CF) | $4.5B | $1.6B | $1.1B | $2.4B | $4.4B | |
| Levered Free Cash Flow | $3B | $3.2B | $2.7B | $3B | $4.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $777.9M | $802.3M | $733.5M | $813.6M | $736.5M | |
| Depreciation & Amoritzation | $120.1M | $137M | $141.1M | $143.3M | $127.9M | |
| Stock-Based Compensation | $12.4M | $14.1M | $17.6M | $22.1M | $25.6M | |
| Change in Accounts Receivable | -$417.6M | -$301.7M | -$217.3M | -$12M | -$107.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $815.4M | $675.3M | $737.6M | $1.4B | $969.9M | |
| Capital Expenditures | $67.1M | $69.1M | $41.5M | $65.1M | $45.4M | |
| Cash Acquisitions | -$29.1K | -$1.1M | -$7.2M | -$449.6K | -$1.2M | |
| Cash From Investing | -$225.4M | $295M | -$7.4M | -$85.9M | $850.7M | |
| Dividends Paid (Ex Special Dividend) | $842.7M | $853.6M | $897.2M | $1B | $1.1B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$29M | -$40M | -- | -- | -- | |
| Repurchase of Common Stock | -$6.1M | $491.9M | $2.2M | -- | $2.1B | |
| Other Financing Activities | -- | -$13M | -- | -- | -- | |
| Cash From Financing | -$864.7M | -$1.4B | -$988.2M | -$1.1B | -$3.2B | |
| Beginning Cash (CF) | $2.1B | $1.4B | $1.6B | $2.7B | $2.2B | |
| Foreign Exchange Rate Adjustment | -$6M | $21.3M | $6.3M | -$28.3M | $18.1M | |
| Additions / Reductions | -$280.8M | -$405.9M | -$251.6M | $119.1M | -$1.4B | |
| Ending Cash (CF) | $1.9B | $1B | $1.4B | $2.8B | $854.8M | |
| Levered Free Cash Flow | $748.2M | $606.2M | $696.1M | $1.3B | $924.5M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.9B | $3B | $3B | $3.3B | $3.2B | |
| Depreciation & Amoritzation | $464.9M | $507.8M | $560.9M | $560.1M | $546.6M | |
| Stock-Based Compensation | $51.3M | $63.5M | $67.6M | $99.6M | $102.8M | |
| Change in Accounts Receivable | -$891.9M | -$1.2B | -$388M | -$231.8M | -$488M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.5B | $3B | $3.2B | $4.4B | $4.2B | |
| Capital Expenditures | $260.7M | $310.1M | $293.3M | $247.8M | $286M | |
| Cash Acquisitions | $10M | $121.7M | -$1M | $391.5M | $69.8M | |
| Cash From Investing | -$954.9M | -$1.2B | $73.6M | -$379.3M | -$132.9M | |
| Dividends Paid (Ex Special Dividend) | $1.7B | $1.7B | $1.8B | $2.4B | $2.1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$108M | -$146M | -- | -- | -- | |
| Repurchase of Common Stock | $1.5B | $489.5M | $938.3M | -$2.2M | $2.1B | |
| Other Financing Activities | $14M | -$43M | -- | -- | -- | |
| Cash From Financing | -$3.3B | -$2.4B | -$3B | -$2.9B | -$4.5B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$817.7M | -$529.6M | $256.9M | $1.1B | -$337.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $3.2B | $2.7B | $2.9B | $4.2B | $3.9B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.2B | $2.3B | $2.2B | $2.4B | $2.4B | |
| Depreciation & Amoritzation | $348.1M | $388.7M | $424.9M | $419.8M | $398.4M | |
| Stock-Based Compensation | $40.7M | $48.3M | $51.5M | $72.3M | $80.4M | |
| Change in Accounts Receivable | -$818.1M | -$920.5M | -$429.8M | -$339.3M | -$618.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.6B | $2.2B | $2.3B | $3.5B | $3.2B | |
| Capital Expenditures | $206.4M | $226M | $199.1M | $181M | $202.9M | |
| Cash Acquisitions | $7.1M | $121.5M | -- | $377.1M | $74.5M | |
| Cash From Investing | -$483.3M | -$544.9M | -$131.8M | $309.9M | $647.6M | |
| Dividends Paid (Ex Special Dividend) | $1.7B | $1.7B | $1.8B | $2.4B | $2.1B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$86M | -$107M | -- | -- | -- | |
| Repurchase of Common Stock | $1.5B | $491.9M | $2.2M | -- | $2.1B | |
| Other Financing Activities | $14M | -$33M | -- | -- | -- | |
| Cash From Financing | -$3.3B | -$2.3B | -$2B | -$2.8B | -$4.5B | |
| Beginning Cash (CF) | $7.4B | $5B | $5.9B | $8.6B | $9B | |
| Foreign Exchange Rate Adjustment | -$10.1M | -$6.3M | $2.1M | -$21M | $97.8M | |
| Additions / Reductions | -$1.2B | -$737M | $178M | $958.4M | -$520.1M | |
| Ending Cash (CF) | $6.3B | $4.3B | $6.1B | $9.6B | $8.6B | |
| Levered Free Cash Flow | $2.4B | $1.9B | $2.1B | $3.3B | $3B | |
Get INFY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
INFY
Sector
P/E ratio
24.98x
24.24x
PEG ratio
21.68x
0.00x
P/B ratio
8.47x
2.21x
Price / LTM sales
4.04x
1.41x
Growth Metrics
INFY
Sector
Revenue growth
3.21%
6.6%
Earnings growth
-6.65%
10.85%
Revenue (5-year growth)
8.53%
4.81%
Earnings forecast
$0.20
$0.15
Profitability
INFY
Sector
Profitability FY 2024
$5.1B
$29.1M
Return on invested capital
27.44%
-0.72%
Return on assets
18.87%
-1.48%
Return on equity
29.93%
0.21%
Earnings Date
Last Earnings Date
Jan
14
Next Earnings Date
Jan
15
Estimated Next Earnings Date
Apr
16
Balance Sheet
INFY
Sector
Total cash
$3B
$38.7M
Short term investments
$1.6B
$16.2M
Total assets
$17.4B
$153.8M
Long term debt
$978.6M
$4.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Buy
53
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
80
BNR alert for Jan 15
Burning Rock Biotech Ltd. [BNR] is up 20.06% over the past day.
Sell
37
TCOM alert for Jan 15
Trip.com Group Ltd. [TCOM] is down 2.9% over the past day.
Sell
39
DAVE alert for Jan 15
Dave, Inc. [DAVE] is up 2.67% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
